Stock A215380 WOOJUNG BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News WOOJUNG BIO, Inc.

Equities

A215380

KR7215380007

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
1,660 KRW -1.19% Intraday chart for WOOJUNG BIO, Inc. -0.30% -20.57%
2023 WOOJUNG BIO, Inc. announced that it has received KRW 5 billion in funding from Korea Investment Partners Co. Ltd. CI
2023 WOOJUNG BIO, Inc. announced that it expects to receive KRW 5 billion in funding from Korea Investment Partners Co. Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
WOOJUNG BIO, Inc. announced that it has received KRW 5 billion in funding from Korea Investment Partners Co. Ltd.
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 5 billion in funding from Korea Investment Partners Co. Ltd.
CI
WOOJUNG BIO, Inc. announced that it has received KRW 8.999979915 billion in funding from Mercury Asset Management Co., Ltd., Ryan Asset Management Co., Ltd., Timefolio Asset Management Co.,Ltd
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 8.999979915 billion in funding from Mercury Asset Management Co., Ltd., Ryan Asset Management Co., Ltd., Timefolio Asset Management Co.,Ltd
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 11 billion in funding
CI
WOOJUNG BIO, Inc. announced that it has received KRW 5 billion in funding
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 5 billion in funding
CI
Chun Byung Nyun acquired an additional 6.4% stake in WOOJUNG BIO, Inc. for KRW 4.4 billion.
CI
WOOJUNG BIO, Inc. announced that it has received KRW 5.00000397 billion in funding
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 5.00000397 billion in funding
CI
ByungNyun Chun, Chief Executive Officer of WOOJUNG BIO, Inc., acquired an additional stake in WOOJUNG BIO, Inc. for KRW 2 billion.
CI
Coronavirus infects Asia stocks with exposure to China
RE
ASX 200 : Coronavirus infects Asia stocks with exposure to China
RE
Tranche Update on WOOJUNG BIO, Inc.'s Equity Buyback Plan announced on November 15, 2017.
CI
WOOJUNG BIO, Inc.'s Equity Buyback announced on November 15, 2017 has expired with 789,780 shares, representing 3.74% for KRW 1,999.89 million.
CI
WOOJUNG BIO, Inc. announced that it has received KRW 2.5 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Focus Investment Co., Ltd.
CI
WOOJUNG BIO, Inc. announced that it has received KRW 10 billion in funding from a group of investors
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 2.5 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Focus Investment Co., Ltd.
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 10 billion in funding from a group of investors
CI
Woojung BSC, Inc. announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A215380 Stock
  4. News WOOJUNG BIO, Inc.